BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12809524)

  • 1. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
    Zhang ZY
    Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
    Zhang ZY
    Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
    Bishop AC; Blair ER
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
    Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
    Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. trans-Beta-nitrostyrene derivatives as slow-binding inhibitors of protein tyrosine phosphatases.
    Park J; Pei D
    Biochemistry; 2004 Nov; 43(47):15014-21. PubMed ID: 15554709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
    Barr AJ; Knapp S
    Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox regulation of protein-tyrosine phosphatases.
    den Hertog J; Groen A; van der Wijk T
    Arch Biochem Biophys; 2005 Feb; 434(1):11-5. PubMed ID: 15629103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic studies on protein tyrosine phosphatases.
    Zhang ZY
    Prog Nucleic Acid Res Mol Biol; 2003; 73():171-220. PubMed ID: 12882518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
    Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
    J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional studies of protein tyrosine phosphatases with chemical approaches.
    Zhang ZY
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives.
    Ferreira CV; Justo GZ; Souza AC; Queiroz KC; Zambuzzi WF; Aoyama H; Peppelenbosch MP
    Biochimie; 2006 Dec; 88(12):1859-73. PubMed ID: 17010496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a modified in-gel assay to identify protein tyrosine phosphatases that are oxidized and inactivated in vivo.
    Meng TC; Hsu SF; Tonks NK
    Methods; 2005 Jan; 35(1):28-36. PubMed ID: 15588983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011).
    Sobhia ME; Paul S; Shinde R; Potluri M; Gundam V; Kaur A; Haokip T
    Expert Opin Ther Pat; 2012 Feb; 22(2):125-53. PubMed ID: 22332719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for developing protein tyrosine phosphatase inhibitors.
    Tautz L; Mustelin T
    Methods; 2007 Jul; 42(3):250-60. PubMed ID: 17532512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.